Zacks Investment ResearchTue, 09 Jun 2026 15:05:53 GMTShould You Add Myriad Genetics Stock to Your Portfolio Right Now?MYGN+4.12%
Zacks Investment ResearchThu, 04 Jun 2026 16:36:15 GMTMyriad (MYGN) Up 7.1% Since Last Earnings Report: Can It Continue?MYGN+4.12%
Zacks Investment ResearchThu, 28 May 2026 14:26:07 GMTMyriad Genetics' Upcoming Prolaris + AI Test Debut May Lift Its StockMYGN+4.12%
Zacks Investment ResearchThu, 28 May 2026 14:21:07 GMTIs MYGN Stock a Buy at 0.4x Sales? What Investors Should WeighMYGN+4.12%
Zacks Investment ResearchWed, 27 May 2026 13:53:45 GMTMYGN Cancer Care Strategy: What's Driving 2026 Growth PlansMYGN+4.12%
Zacks Investment ResearchMon, 18 May 2026 14:35:30 GMTDown 29.5% in 4 Weeks, Here's Why You Should You Buy the Dip in Myriad (MYGN)MYGN+4.12%
Seeking AlphaWed, 06 May 2026 03:31:15 GMTMyriad Genetics, Inc. (MYGN) Q1 2026 Earnings Call TranscriptMYGN+4.12%
Zacks Investment ResearchWed, 06 May 2026 01:31:12 GMTMyriad Genetics (MYGN) Reports Q1 Loss, Misses Revenue EstimatesMYGN+4.12%
Seeking AlphaTue, 31 Mar 2026 21:29:29 GMTMyriad Genetics: SOTP Suggests The Company Is UndervaluedMYGN+4.12%
